Charles Raubicheck, head of our firm’s FDA practice, will chair a panel and deliver an address at the “U.S. & Brazil Conference: Navigating New Frontiers in Pharmaceutical, Medical Device and Food Law and Regulation,” to be held on September 10-11, 2012 in Sao Paolo, Brazil.
The conference, sponsored by The Food and Drug Law Institute (“FDLI”), will bring together representatives of companies, venture capital firms, government agencies, law firms and other groups involved in the drug, device and food industries. They will engage in high-level discussions about respective commercial, trade, legal and other aspects of doing business in this country and Brazil, the world’s 6th largest economy.
Mr. Raubicheck’s panel will focus on the interplay between regulatory and intellectual property issues pertinent to pharmaceuticals. His presentation is entitled “NDAs, ANDAs, FDA’s Orange Book, and Patent Term Extensions.”